Abstract
In the developed world, all routine clinical laboratories should be able to perform tests for the assessment of the pituitary–thyroid axis. Testing strategies usually involve the measurement of thyroid-stimulating hormone (TSH), either alone or in combination with free thyroxine (FT4), which itself should also be measured when TSH is abnormal or if there is a suspicion of pituitary disease. Based on these findings, clinical history and medications such as amiodarone, free tri-iodothyronine (FT3), thyroid-binding globulin (TBG), and/or autoantibodies may then be measured.
All these assays have their individual challenges. For example, sensitivity of a TSH assay is of crucial importance for improving distinction between eu- and hyperthyroidism. In the measurement of free hormones, there is the potential disturbance of the equilibrium between free and bound moieties by separating systems. There are a number of commercial diagnostic kits available for each of these tests. This chapter presents various representative assays and their principles. With the exception of FT4 determination by equilibrium dialysis, those that employ a 96-well plate format and use non-isotopic techniques have been described. Attention has been paid to limitations of the assays, standardization of assay kits, imprecision, recovery, detection limit, and ease of use. The assays described have been given as typical and reliable examples, but it is the responsibility of assayists to choose methods that are best suited to their needs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Association of Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation (2006) UK guidelines for the use of thyroid function tests. http://acb.org.uk/docs/tftguidelinefinal.pdf (Accessed July 2013)
Stockigt J (2003) Assessment of thyroid function: towards an integrated laboratory—clinical approach. Clin Biochem Rev 24:109–122
Beckett G, Toft T, O’Kane M (2007) Thyroid function tests in the UK. www.acb.org.uk/docs/TFTprofile.pdf (Accessed July 2013)
Snyder PJ, Utiger RD (1972) Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest 51:2077–2084
Vagenakis AG, Rapoport B, Azizi F et al (1974) Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 54:913–918
Spencer CA, Takeuchi M, Kazarosyan ME (1995) Interlaboratory differences in functional sensitivity of immunometric assays of thyrotropin and impact on relaibility of measurement of subnormal concnetrations of TSH. Clin Chem 4:367–374
Spencer CA, Takeuchi M, Kazarosyan M (1996) Current status and performance goals for serum TSH assays. Clin Chem 42:140–145
Hay ID, Bayer MF, Kaplan MM et al (1991) American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurementsand guidelines for future clinical assays. Clin Chem 37:2002–2008
Mendel CM (1989) The free hormone hypothesis: a physiolocally based mathematical model. Endocr Rev 10:232–274
Mendel CM (1992) The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl 13:107–116
Ekins R (1990) Measurements of free hormones in blood. Endocr Rev 11:5–46
Ekins R (1992) The free hormone hypothesis and measurement of free hormones. Clin Chem 38:1289–1293
Yue B, Rockwood AL, Sandrock T et al (2008) Free thyroid hormones in serum by direct equilibrium dialysis and online solid-pahse extraction-liquid chromatography/tandem mass spectrometry. Clin Chem 54:642–651
Csako G, Zweig MH, Glickman J et al (1989) Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. I. Effect of free fatty acids. Clin Chem 35:102–109
Nelson JC, Weiss RM (1985) The effects of serum dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 61:239–246
Holm SS, Andreasen L, Hansen SH et al (2002) Influence of adsorption and deproteination on potential free thyroxine reference methods. Clin Chem 48:108–114
Tikanoja SH (1990) Ultrafiltration devices tested for use in a free thyroxine assay validated by comparison with equilibrium dialysis. Scand J Clin Lab Invest 50:663–669
Romelli PB, Penrisi F, Vancheri L (1979) Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay. J Endocrinol Invest 2:25–40
Jonklaas J, Kahric-Janicic N, Soldin OP et al (2009) Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin Chem 55:1380–1388
Gu J, Soldin OP, Soldin SJ (2007) Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem 40:1386–1391
Christofides ND, Midgley JE (2009) Inaccuracies in free thyroid hormone measurement by ultrafiltration and tandem mass spectrometry. Clin Chem 55:2228–2229
Ross HA, Bernardm TJ (1992) Is free thyroxine accurately measurabe at room temperature? Clin Chem 38:880–887
van der Sluijs Veer G, Vermes I, Bonte HA et al (1992) Temperature effects on free thyroxine measurements: analytical and clinical consequences. Clin Chem 38:1327–1331
Csako G, Zwieg MH, Glickman J et al (1989) Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. II. Effect of prealbumin, albumin and thyroxin-binding globulin. Clin Chem 35:1655–1662
Stockigt JR, Lim CF (2009) Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 23:753–767
Midgley JEM (2001) Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem 47:1353–1363
Burr WA, Evans SE, Lee J et al (1979) The ratio of thyroxine to thyroxine-binding globulin measurement in the evaluation of thyroid function. Clin Endocrinol 11:333–342
Attwood EC, Atkin GE (1982) The T4: TBG ratio: a re-evaluation with particular reference to low and high serum TBG levels. Ann Clin Biochem 19:101–103
Szpunar WE, Stoffer SS, DiGiulio W (1987) Clinical evaluation of a thyroxine binding globulin assay in calculationg a free thyroxine index in normal, thyroid disease and sick euthyroid patients. J Nucl Med 28:1341–1343
Nelson JC, Tomei RT (1989) Dependence of the thyroxin/thyroxin-binding globulin (TBG) ratio and the free thyroxin index on TBG concentrations. Clin Chem 35:541–544
Wilcox RB, Nelson JC, Tomei RT (1994) Heterogeneity in affinities of serum proteins for thyroxine among patients with non-thyroidal illness as indicated by the serum free thyroxine response to serum dilution. Eur J Endocrinol 131:9–13
Evans SE, Burr WA, Hogan TC (1977) A reassessment of 8-anilino-1-naphthalene sulphonic acid as a thyroxine binding inhibitor in the radioimmunoassay of thyroxine. Ann Clin Biochem 14:330–334
Mariotti S, Caturegli P, Piccolo P et al (1990) Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 71:661–669
Feldt-Rasmussen U, Hoier-Madsen M, Bech K et al (1991) Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity 9:245–253
Gilmour J, Brownlee Y, Foster P et al (1991) The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto’s disease, Graves’ disease and a follow-up study on postpartum thyroid disease. Clin Lab 46:57–61
Finke R, Bogner U, Kotulla P et al (1994) Anti-TPO antibody determinations using different methods. Exp Clin Endocrinol 102:145–150
Feldt-Rasmussen U (1996) Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem 42:160–163
Smith BR, Sanders J, Furmaniak J (2007) TSH receptor antibodies. Thyroid 17:923–938
Ando T, Latif R, Davies TF (2005) Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 19:33–52
Mizutori Y, Chen CR, Latrofa F et al (2009) Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves’ disease. J Clin Endocrinol Metab 94:927–935
Ajjan RA, Weetman AP (2008) Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 4:461–468
Sinclair D (2008) Analytical aspects of thyroid antibodies estimation. Autoimmunity 41:46–54
Smith BR, Bolton J, Young S et al (2004) A new assay for thyrotropin receptor antibodies. Thyroid 14:830–835
Kamijo K, Ishilawa K, Tanaka M (2005) Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 52:525–529
Zöphel K, Roggenbuck D, von Landenberg P et al (2010) TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res 42:65–69
Theodoraki A, Jones G, Parker J et al (2011) Performance of a third generation TSH-receptor antibody (TRAb) in a UK clinic. Clin Endo-crinol 75:127–133
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Morovat, A. (2013). Methods for the Investigation of Thyroid Function. In: Wheeler, M. (eds) Hormone Assays in Biological Fluids. Methods in Molecular Biology, vol 1065. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-616-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-616-0_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-615-3
Online ISBN: 978-1-62703-616-0
eBook Packages: Springer Protocols